DIU de rythmologie et stimulation cardiaque. Orateur : Serge BOVEDA Le 25 janvier 2012

Size: px
Start display at page:

Download "DIU de rythmologie et stimulation cardiaque. Orateur : Serge BOVEDA Le 25 janvier 2012"

Transcription

1 DIU de rythmologie et stimulation cardiaque Titre : Fibrillation atriale paroxystique : ablation, résultats, complications Orateur : Serge BOVEDA Le 25 janvier 2012

2 Fibrillation Atriale Paroxystique : ablation, résultats, complications DIU Rythmologie Paris, le 25/01/12 s.boveda@clinique-pasteur.com

3 1 A disease with bad consequences RR de patients en FA comparé avec des patients sans FA ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation Population de FA X 2 entre 1995 et 2030 Go et al, JAMA 2001

4 1 Afib ablation : is it THE Solution? Mortality, Morbidity, and Quality of Life after Circumferential Pulmonary Vein Ablation for Atrial Fibrillation Outcomes from a Controlled Nonrandomized Long-term Study Pappone C et al. J Am Coll Cardiol 2003 Pulmonary vein ablation improves mortality, morbidity, and QoL as compared with medical therapy Our findings pave the way for randomized trials to prospect a wider application of ablation for AF All patients should be ablated...

5 2 Afib ablation : theoretical aspects Haissaguerre M et al. NEJM 1998

6 2 Afib ablation : theoretical aspects Foyer FA

7 2 Afib ablation : theoretical aspects

8 2 Afib ablation : theoretical aspects * * * * *

9 Strategy of Afib ablation Initiation = Paroxysmal = Persistent Sustained = LA substrate Primary focuses (95% PV) Focal ablation Altered Tissue Linear lesions

10 2 Afib ablation : theoretical aspects

11 2 Afib ablation : theoretical aspects 3-D + Irrigated Single shot tools Kuck, Pappone Pappone Pappone Lasso + Irrigated Bordeaux 2000 Bordeaux 1999 Bordeaux 2001

12 3 Afib ablation : technical aspects Decapolar Lasso Catheter for PV mapping

13 3 Afib ablation : technical aspects VPSD VPSG VPID VPIG

14 3 Afib ablation : technical aspects Kato R. et al. Circulation 2003;107:

15 Bilan anatomique des veines pulmonaires Angiographie per-procédure, IRM, TDM multibarrettes +++ :

16 3 Afib ablation : technical aspects All 4 veins deconnection assessed by the absence of PV potential at the ostium of each vein Control of the 4 veins just before removing the catheters (frequent recurrences +++)

17 Right superior PV before/after RF

18 Left superior PV before/after RF

19 LIPV disconnection

20

21

22

23

24 Follow-up - Holter just after the procedure, after 3, 6 and 12 months - Warfarin at least during 6 months in case of afib recurrences

25 Why still so much recurrences?

26 3 Afib ablation : technical aspects Navigation systems Nowadays: Carto 3

27 Circumferential PVI Arentz T. Circulation 2007

28 PV Isolation: the larger the better? 110 Patients Ostial segmental PVI = small isolation Circumferential Isolation = large isolation Arentz et al. Circulation 2007

29 PV Isolation: the larger the better!!! Arentz et al. Small or large isolation areas around the PVs. Circulation 2007

30 3 Afib ablation : technical aspects Single shot tools for paroxysmal AFib

31 PVAC : pulmonary vein ablation catheter I III V1 PVAC 1 PVAC 2 PVAC 3 PVAC 4 PVAC 5 CS prox CS dist 1 Minute Ablation time

32 PAF Typical baseline ECG

33 Afib coming from RSPV

34 LSPV before RF ablation

35 LSPV after first RF application : 1 st degree PV block

36 LSPV after RF ablation

37 Pacing inside LSPV showing LA dissociation

38 Pacing inside LIPV : still connected

39 LIPV pre RF ablation

40 LIPV post RF ablation

41 RSPV pre RF ablation

42 RSPV dissociation after RF ablation

43 RIPV pre RF ablation

44 RIPV post RF ablation

45 3 Afib ablation : technical aspects Cryoablation - Methods 240 sec per application 23 mm 28 mm At least 2 applications per vein with good occlusion achieved during venography, through <-40 Size of the balloon : - 28 mm or 23 mm according to : the PV diameter (CT scan > or < 15/16 mm), Gender: Women, low BMI : 23 mm ++ Size of the RSPV

46

47 Cryoablation is it superior to radiofrequency ablation? Cryolesion1 week (dog, LV) Freezor 4 mm, -75 C, 240 s Less endocardial disruption Preservation of underlying tissue architecture reduce platelet and clotting activation and thrombus formation > thromboembolism Khairy P, et al. Circulation. 2003;107:

48 If the diameter of the PVs is >15 mm 28 mm balloon

49 LSPV /Achieve

50 Achieve in the LSPV, isolation at 35 s freeze during CS pacing

51 (1) Paroxysmal AF, Achieve in the LSPV, without pacing - Where is the A potential? - Where is the venous potential? where is the ventricular potential?

52 (2) During cryo ablation at 15 sec

53 4 Afib ablation : results Parox AF ablation: success rate Meta-analysis of catheter ablation studies Ablation method Patients Paroxysmal AF SHD 6 mo cure 6 mo OK Linear % 26 % 33 % 55 % Focal % 35 % 54 % 71 % Isolation 2, % 36 % 62 % 75 % Circumferential (all) 15, % 37 % 64 % 74 % Circumferential (LACA, WACA) 2, % 37 % 59 % 72 % Circumferential (PVAI) 11, % 42 % 67 % 76 % Substrate ablation (CFAE) % 49 % 75 % 87 % Total 23, % 55 % 63 % 75 % The VeniceChart international consensus document

54 PAF Ablation : Randomized Studies AF - ESC Guidelines, EHJ 2010

55 Study Design of the STOP-AF Trial Inclusions: Patients >2 AF episodes in 2 months w ECG doc. of 1 Rx Failure of > 1 AA Rx Follow- up 1,3,6,9, &12 mo Holters Weekly TTMs

56 Primary Effectiveness Analysis Treatment Success days Treatment success (%) Blanked CRYO 69.9% 114/163 P<0.001) DRUG Rx 7.3% 6/ KM estimate 68.6% (SE 3.9%) Days vs 7.3% (SE 2.9%)

57 4 Afib ablation : CP results

58 4 Afib ablation : CP results Success without AAD Success with AAD Paroxysmal Afib Persistent/ Afib (1 year) 72 % 80 % 52 % 63 %

59 4 Afib ablation : elderly patients Zado et al, J Cardiovasc Electrophysiol 2008

60 4 Afib ablation : athletes patients In patients with documented focal induction of nonpermanent AF and absence of structural heart disease, PVI is as effective in athletes as in other patients Koopman P, Europace 2011

61 5 Afib ablation : complications Accès Percutané Complications «locales» : Fistule artério/veineuse, Hématome fémoral Manipulation cathéters / Ponction Transeptale Perforation cardiaque / Tamponnade ; Perforation du sinus coronaire ; lésion aortique Energie Délivrée Perforation cardiaque / Tamponnade ; Lésion valvulaire ; AVC ; Fistule oesophagienne

62 5 Afib ablation : complications Verma A et al. ( Circulation 2005;112: ) Global risk between 2 and 3% (higher for persistent Afib?...)

63 5 Afib ablation : complications AVC : incidence = 0 à 4%... ACT (per-op + post-op) Surveillance clinique per-op + post-op Stroke center / Fibrinolyse Troughton R, Heart 2003 Dixit S, Heart Rhythm 2007

64 5 Afib ablation : complications Tamponnade : incidence = 1.2 à 6%... Drainage sous-xyphoïdien Chirurgie +++ Wu R, J Cardiovasc Electrophysiol 2002

65 5 Afib ablation : complications Fistule atrio œsophagienne : incidence < 0.25% / Mortalité = 50%... Sra J, J Interv Card Electrophysiol 2008 Dixit S, Heart Rhythm 2007

66 5 Afib ablation : complications PV stenosis : up to 15% / Severe >70% : 1-3% Sra J, J Interv Card Electrophysiol 2008

67 5 Afib ablation : complications Asymptomatic PV stenosis 3 months after ablation

68 6 Looking at the Guidelines?

69 6 Looking at the Guidelines

70 7 Should we ablate before? This suggests that the selection of patients for the invasive strategy should be considered at an earlier stage of the disease, even before AAD Europace 2011

71 Take Home Message 1. Symptomatic parox Afib ablation after AAD failure is a IIa / I indication with a 75% success and 2-3% complication rates 2. Afib ablation is cost-effective in these patients 3. Persistent Afib ablation remains challenging, with long fluoro exposure time, higher morbidity and lower success rates 4. Afib type, absence of SHD, LA enlargement, LA fibrosis/srm seem to be important factors for a better outcome after ablation 5. try to ablate before Afib becomes persistent 6. at earlier stages of the disease 7. but not before AAD treatment : IIb indication

Ablation For Atrial Fibrillation. Bill Petrellis Electrophysiologist

Ablation For Atrial Fibrillation. Bill Petrellis Electrophysiologist Ablation For Atrial Fibrillation Bill Petrellis Electrophysiologist AF is the most common arrhythmia in the Western world Prevalence 1.1% in Australia conservative estimate - 240,000 June 2009 AF is an

More information

Management of Symptomatic Atrial Fibrillation

Management of Symptomatic Atrial Fibrillation Management of Symptomatic Atrial Fibrillation John F. MacGregor, MD, FHRS Associate Medical Director, Cardiac Electrophysiology PeaceHealth St. Joseph Medical Center, Bellingham, WA September 18, 2015

More information

How do you decide on rate versus rhythm control?

How do you decide on rate versus rhythm control? How do you decide on rate versus rhythm control? Dr. Mark O Neill Consultant Cardiologist & Electrophysiologist Assumptions Camm et al. EHJ 2010;Sept 25 epub Choice of strategy: Criteria for consideration

More information

DISCLOSURE. Atrial Fibrillation Management An Evidence-based Approach OBJECTIVES BACKGROUND AFFIRM 9/16/2015

DISCLOSURE. Atrial Fibrillation Management An Evidence-based Approach OBJECTIVES BACKGROUND AFFIRM 9/16/2015 Death (%) Mortality (%) 9/16/2015 DISCLOSURE Atrial Fibrillation Management An Evidence-based Approach Jonathon Adams, MD, FHRS Relevant Financial Relationship(s) None Off Label Usage None OBJECTIVES What

More information

The Decision Tree for Ablation Therapy in Atrial Fibrillation Colin Movsowitz, MD, FACC Cardiology Consultants of Philadelphia Director of Electrophysiology Einstein Medical Center Montgomery Co-Director

More information

Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial

Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial Lucas Boersma, WimJan van Boven, Alaaddin Yilmaz, Johannes Kelder, Maurits Wijffels

More information

How do you decide on rate versus rhythm control?

How do you decide on rate versus rhythm control? Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study

More information

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? Indiana Chapter-ACC 17 th Annual Meeting Indianapolis, Indiana October 19, 2013 Deepak Bhakta MD FACC FACP FAHA FHRS CCDS Associate

More information

Vorhofflimmern und Schlaganfall Ablation, Antikoagulation, Vorhofohrverschluß was wann für wen? B. Keweloh Unfallkrankenhaus Berlin

Vorhofflimmern und Schlaganfall Ablation, Antikoagulation, Vorhofohrverschluß was wann für wen? B. Keweloh Unfallkrankenhaus Berlin Vorhofflimmern und Schlaganfall Ablation, Antikoagulation, Vorhofohrverschluß was wann für wen? B. Keweloh Unfallkrankenhaus Berlin B. Keweloh 16.11.2013 Incidence of Atrial Fibrillation, Standard population

More information

How should we treat atrial fibrillation in heart failure

How should we treat atrial fibrillation in heart failure Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 23/24 Ottobre 2015 How should we treat atrial fibrillation in heart failure Matteo Anselmino Dipartimento Scienze Mediche Città

More information

2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them?

2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them? 2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them? Gaetano Senatore DIVISION OF CARDIOLOGY HOSPITAL OF CIRIE

More information

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of

More information

Sporadic or short episodes of paroxysmal atrial fibrillation - still a need for antithrombotic therapy?

Sporadic or short episodes of paroxysmal atrial fibrillation - still a need for antithrombotic therapy? Sporadic or short episodes of paroxysmal atrial fibrillation - still a need for antithrombotic therapy? Carina Blomström Lundqvist Dept Cardiology, Uppsala University, Sweden Patterns of AF Terminates

More information

Presenter Disclosure Information

Presenter Disclosure Information 2:15 3 pm Managing Arrhythmias in Primary Care Presenter Disclosure Information The following relationships exist related to this presentation: Raul Mitrani, MD, FACC, FHRS: Speakers Bureau for Medtronic.

More information

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence

More information

Atrial Fibrillation An update on diagnosis and management

Atrial Fibrillation An update on diagnosis and management Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.

More information

Recurrent AF: Choosing the Right Medication.

Recurrent AF: Choosing the Right Medication. In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department

More information

Combined Epicardial and Endocardial Ablation for Treatment of Atrial Fibrillation. Ashkan Babaie MD Providence Portland Medical Center

Combined Epicardial and Endocardial Ablation for Treatment of Atrial Fibrillation. Ashkan Babaie MD Providence Portland Medical Center Combined Epicardial and Endocardial Ablation for Treatment of Atrial Fibrillation Ashkan Babaie MD Providence Portland Medical Center 1 Disclosures None 2 Cox-Maze III The Godfather Cure rates > 95% in

More information

Atrial Fibrillation and Ablation Therapy: A Patient s Guide

Atrial Fibrillation and Ablation Therapy: A Patient s Guide Atrial Fibrillation and Ablation Therapy: A Patient s Guide ATRIAL FIBRILLATION CENTER AT UNIVERSITY OF ROCHESTER MEDICAL CENTER www.heart.urmc.edu 585-275-4775 INTRODUCTION Our goal at the Atrial Fibrillation

More information

How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy

How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy L. Pison, MD Advances in Cardiac Arrhythmias and Great Innovations in Cardiology - Torino, September 28 th 2013

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

Management of Atrial Fibrillation in Heart Failure

Management of Atrial Fibrillation in Heart Failure Disadvantages of AV Junction Ablation Persistent AFib- no AV synchrony Ongoing risk of thromboembolism Life-long dependency on pacemaker Comparison of LA Ablation vs. AVN Ablation LA Ablation AVN Ablation

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

Atrial Fibrillation (AF) March, 2013

Atrial Fibrillation (AF) March, 2013 Atrial Fibrillation (AF) March, 2013 This handout is meant to help with discussions about the condition, and it is not a complete discussion of AF. We hope it will complement your appointment with one

More information

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia

More information

Ngaire has Palpitations

Ngaire has Palpitations Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.

More information

Atrial Fibrillation Cardiac rate control or rhythm control could be the key to AF therapy

Atrial Fibrillation Cardiac rate control or rhythm control could be the key to AF therapy Cardiac rate control or rhythm control could be the key to AF therapy Recent studies have proven that an option of pharmacologic and non-pharmacologic therapy is available to patients who suffer from AF.

More information

Förmaksflimmer ablation - en uppdatering och guidelines. Carina Blomström Lundqvist, Dept.of Cardiology, Uppsala University Hospital.

Förmaksflimmer ablation - en uppdatering och guidelines. Carina Blomström Lundqvist, Dept.of Cardiology, Uppsala University Hospital. Förmaksflimmer ablation - en uppdatering och guidelines Carina Blomström Lundqvist, Dept.of Cardiology, Uppsala University Hospital. Cardiac Surgery for AF management Maze I Maze II Maze III 1987-1992

More information

Techniques of Mapping and Isolation of the Pulmonary Veins in Patients with Atrial Fibrillation

Techniques of Mapping and Isolation of the Pulmonary Veins in Patients with Atrial Fibrillation Aus dem Deutschen Herzzentrum Berlin Klinik für Innere Medizin/Kardiologie DISSERTATION Techniques of Mapping and Isolation of the Pulmonary Veins in Patients with Atrial Fibrillation zur Erlangung des

More information

Catheter Ablation of Arrhythmogenic Foci as Treatment for Atrial Fibrillation

Catheter Ablation of Arrhythmogenic Foci as Treatment for Atrial Fibrillation Catheter Ablation of Arrhythmogenic Foci as Treatment for Atrial Fibrillation Policy Number: Original Effective Date: MM.06.011 09/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration

More information

Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015

Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015 Atrial Fibrillation: Drugs, Ablation, or Benign Neglect Robert Kennedy, MD October 10, 2015 Definitions 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary.

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Catheter Ablation as a Treatment for Atrial Fibrillation File Name: Origination: Last CAP Review: Next CAP Review: Last Review: catheter_ablation_as_a_treatment_for_atrial_fibrillation

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Catheter Ablation as Treatment Page 1 of 29 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Catheter Ablation as Treatment Professional Institutional Original Effective

More information

Managing the Patient with Atrial Fibrillation

Managing the Patient with Atrial Fibrillation Pocket Guide Managing the Patient with Atrial Fibrillation Updated April 2012 Editor Stephen R. Shorofsky, MD, Ph.D. Assistant Editors Anastasios Saliaris, MD Shawn Robinson, MD www.hrsonline.org DEFINITION

More information

Atrial Fibrillation The Basics

Atrial Fibrillation The Basics Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation

More information

Name of Policy: Transcatheter Ablation of Arrhythmogenic Foci as a Treatment of Atrial Fibrillation

Name of Policy: Transcatheter Ablation of Arrhythmogenic Foci as a Treatment of Atrial Fibrillation Name of Policy: Transcatheter Ablation of Arrhythmogenic Foci as a Treatment of Atrial Fibrillation Policy #: 283 Latest Review Date: June 2015 Category: Medical Policy Grade: A Background/Definitions:

More information

Il destino dei pazienti dopo ablazione della fibrillazione atriale

Il destino dei pazienti dopo ablazione della fibrillazione atriale Tigullio Cardiologia 2014 La terapia della fibrillazione atriale: Il destino dei pazienti dopo ablazione della fibrillazione atriale N. Bottoni Responsabile U.O.S. Aritmologia Interventistica, Az. Ospedaliera

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): April 26, 2011 Most Recent Review Date (Revised): January 27, 2015 Effective Date: April 1, 2015 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT

More information

Projected Number of Adults With AF in the US. Review the growing incidence and importance of AF in the population

Projected Number of Adults With AF in the US. Review the growing incidence and importance of AF in the population Atrial Fibrillation Troy E. Rhodes, MD, PhD Division of Cardiovascular Medicine, Electrophysiology Ohio State University Medical Center Learning Objectives Review the growing incidence and importance of

More information

A focus on atrial fibrillation

A focus on atrial fibrillation A focus on atrial fibrillation Is being female really a risk factor for stroke? Dr Justin Mariani MBBS BMedSci PhD FRACP FCSANZ Consultant Cardiologist and Interventional Heart Failure Specialist Alfred

More information

Introduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center

Introduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center Introduction to Electrophysiology Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center Objectives Indications for EP Study How do we do the study Normal recordings Abnormal Recordings Limitations

More information

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological

More information

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation

More information

Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015

Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015 Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015 Disclaimer I have no relationships to disclose Do we have a cure for Atrial Fibrillation? The short

More information

Difficult Cases in Atrial Fibrillation. Ascot Cardiology GP Symposium April 2014

Difficult Cases in Atrial Fibrillation. Ascot Cardiology GP Symposium April 2014 Difficult Cases in Atrial Fibrillation Ascot Cardiology GP Symposium April 2014 Atrial Fibrillation 1-2% general population 40-50yrs

More information

National Medical Policy

National Medical Policy National Medical Policy Subject: Policy Number: Catheter Ablation for Atrial Fibrillation NMP175 Effective Date*: May 2010 Update: July 2015 This National Medical Policy is subject to the terms in the

More information

The intensity and duration of monitoring should be determined by the clinical need to establish the diagnosis

The intensity and duration of monitoring should be determined by the clinical need to establish the diagnosis Cardiology and Vascular Medicine ESC Update Programme in Cardiology Rotterdam, June 12 th, 2012 Atrial Fibrillation ESC Guidelines: Paroxysmal Atrial Fibrillation Irene Savelieva St George s University

More information

Atrial fibrillation How is treatment changing? Charles Henrikson, MD Director, Electrophysiology Service 1 February 2014

Atrial fibrillation How is treatment changing? Charles Henrikson, MD Director, Electrophysiology Service 1 February 2014 Atrial fibrillation How is treatment changing? Charles Henrikson, MD Director, Electrophysiology Service 1 February 2014 Outline Introduction Natural history of afib and stroke Current risk stratification

More information

Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014

Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014 Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014 Atrial Fibrillation 2 Atrial Fibrillation The most common arrhythmia encountered

More information

CATHETER ABLATION for ATRIAL FIBRILLATION

CATHETER ABLATION for ATRIAL FIBRILLATION CATHETER ABLATION for ATRIAL FIBRILLATION Atrial Fibrillation Clinic Dr. Richard Leather, Dr. Larry Sterns, Dr Paul Novak, Dr. Chris Lane Royal Jubilee Hospital Block 3 rd floor, Rm 343 1952 Bay Street

More information

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular Mitral Regurgitation Anatomy Mechanisms of MR Presentation Evaluation Management Repair Replace Clip

More information

Atrial Fibrillation Management Across the Spectrum of Illness

Atrial Fibrillation Management Across the Spectrum of Illness Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,

More information

BIOSENSE WEBSTER NAVISTAR THERMOCOOL Catheter for Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation FDA review of P030031/S11

BIOSENSE WEBSTER NAVISTAR THERMOCOOL Catheter for Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation FDA review of P030031/S11 BIOSENSE WEBSTER NAVISTAR THERMOCOOL Catheter for Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation FDA review of P030031/S11 Benjamin C. Eloff, Ph.D. Division of Cardiovascular Devices

More information

New in Atrial Fibrillation

New in Atrial Fibrillation New in Atrial Fibrillation September 2011 Stroke prevention more options Rhythm Control -drugs - alternatives to drugs; ablation Rate Control - pace + ablate A-FIB Dell Stroke Risk AFib Two Principles

More information

Surgeons Role in Atrial Fibrillation

Surgeons Role in Atrial Fibrillation Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)

More information

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter 22 July 2010 EMA/CHMP/EWP/213056/2010 Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter Draft Agreed by Efficacy Working Party July 2008 Adoption by CHMP for release

More information

The debate: Should all AF patients see an EP consultant?

The debate: Should all AF patients see an EP consultant? The debate: Should all AF patients see an EP consultant? Pre-debate show of hands in favour of the motion The argument for the motion: Dr Nick Kelland The argument against the motion: Dr Andy McCoye Discussion

More information

Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial

Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial Camillo Autore Università di Roma Sapienza II Facoltà di Medicina e Chirurgia

More information

A Patient Guide to Atrial Fibrillation and Catheter Ablation

A Patient Guide to Atrial Fibrillation and Catheter Ablation A Patient Guide to Atrial Fibrillation and Catheter Ablation Al-Sabah Arrhythmia Institute 1111 Amsterdam Avenue New York, NY 10025 Phone: 212-523-2400 Fax: 212-523-2571 www.stlukescardiology.org Printed

More information

Rome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE

Rome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE Rome, Italy December 4-7, 2012 Rome Cavalieri Monday, December 3 ROOM Terrazza Monte Mario PATIENT MANAGEMENT CONCEPTS AND CONTROVERSIES IN ELECTROPHYSIOLOGY BIOTRONIK International Fellows Program (IFP)

More information

New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation. Joy Wahawisan, Pharm.D., BCPS April 25, 2012

New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation. Joy Wahawisan, Pharm.D., BCPS April 25, 2012 New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation Joy Wahawisan, Pharm.D., BCPS April 25, 2012 Stroke in Atrial Fibrillation % Stroke 1991;22:983. Age Range (years) CHADS 2 Risk

More information

Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey

Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey Europace (215) 17, 1596 16 doi:1.19/europace/euv2 EP WIRE Current techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey Nikolaos Dagres 1 *, Maria Grazia

More information

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated

More information

Electrocardiographic Issues in Williams Syndrome

Electrocardiographic Issues in Williams Syndrome Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital

More information

DISCLOSURES. I am a consultant for Biosense Webster St Jude Medical

DISCLOSURES. I am a consultant for Biosense Webster St Jude Medical Ablation vs. Amiodarone for Treatment of Atrial Fibrillation in Patients with Congestive Heart Failure and an Implanted ICD/CRTD (AATAC-AF in Heart Failure) ClinicalTrials.gov Identifier: NCT00729911/

More information

TABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours)

TABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours) Clinical Practice Guidelines for the Management of Patients With Atrial Fibrillation Deborah Ritchie RN, MN, Robert S Sheldon MD, PhD Cardiovascular Research Group, University of Calgary, Alberta Partly

More information

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7

More information

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long

More information

Antiplatelet and Antithrombotics From clinical trials to guidelines

Antiplatelet and Antithrombotics From clinical trials to guidelines Antiplatelet and Antithrombotics From clinical trials to guidelines Ashraf Reda, MD, FESC Prof and head of Cardiology Dep. Menofiya University Preisedent of EGYBAC Chairman of WGLVR One of the big stories

More information

ATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014

ATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014 ATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014 Facts 4 million or so people have atrial fibrillation 16 billion dollars spent yearly in USA 30% of strokes attributable to AF and AFL 3-5

More information

Radiofrequency Ablation for Atrial Fibrillation. A Guide for Adults

Radiofrequency Ablation for Atrial Fibrillation. A Guide for Adults Radiofrequency Ablation for Atrial Fibrillation A Guide for Adults Fast Facts n There are different ways to treat atrial fibrillation (A-fib). One kind of treatment involves putting the heart back into

More information

Contact force technology in catheter ablation of atrial fibrillation

Contact force technology in catheter ablation of atrial fibrillation Contact force technology in catheter ablation of atrial fibrillation Anna Wysocka 1, Maciej Wójcik 2 1 Chair of Internal Medicine and Department of Internal Medicine in Nursing, Medical University, Lublin,

More information

Non-surgical treatment of severe varicose veins

Non-surgical treatment of severe varicose veins Non-surgical treatment of severe varicose veins Yasu Harasaki UCHSC Department of Surgery General Surgery Grand Rounds March 19, 2007 Definition Dilated, palpable, subcutaneous veins generally >3mm in

More information

Pulmonary Vein İsolation with the Cryoballoon: Simpler, Faster But Equally Effective?

Pulmonary Vein İsolation with the Cryoballoon: Simpler, Faster But Equally Effective? Pulmonary Vein İsolation with the Cryoballoon: Simpler, Faster But Equally Effective? Gian Battista Chierchia M.D., Antonio Sorgente M.D., Fatih Bayrak M.D., Andrea Sarkozy M.D., Carlo De Asmundis M.D.,

More information

ATRIAL FIBRILLATION: Scope of the Problem. October 2015

ATRIAL FIBRILLATION: Scope of the Problem. October 2015 ATRIAL FIBRILLATION: Scope of the Problem October 2015 Purpose of the Presentation Review the worldwide incidence and prognosis associated with atrial fibrillation (AF) Identify the types of AF, clinical

More information

National Medicines Information Centre

National Medicines Information Centre National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 www.nmic.ie THE CONTEMPORARY MANAGEMENT OF ATRIAL FIBRILLATION VOLUME 12 NUMBER 3 2006

More information

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Atrial Fibrillation: A Different Perspective Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Faculty/Presenter Disclosure Faculty: Dr. Michael Heffernan Relationships with commercial

More information

None. Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management. 76 year old male LINGO 1/5/2015

None. Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management. 76 year old male LINGO 1/5/2015 Financial Disclosure Information Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management Robert D. McBane, M.D. Division of Cardiology Mayo Clinic Rochester Dual Antiplatelet

More information

SECTION I: Request. SECTION II: Need. Program Description

SECTION I: Request. SECTION II: Need. Program Description SECTION I: Request This is a formal request for the Utah CARMA Center to be formally recognized by the University of Utah as a large, collaborative medical and academic center whose focus is on comprehensive

More information

Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose

Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.

More information

Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation

Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation Albert L.Waldo, MD KEYWORDS Atrial fibrillation Oral anticoagulation Stroke risk EPIDEMIOLOGY OF STROKE RISK It is well recognized

More information

1/7/2012. Objectives. Epidemiology of Atrial Fibrillation(AF) Stroke in AF. Stroke Risk Stratification in AF

1/7/2012. Objectives. Epidemiology of Atrial Fibrillation(AF) Stroke in AF. Stroke Risk Stratification in AF Objectives Atrial Fibrillation and Prevention of Thrombotic Complications: Therapeutic Update Andrea C. Flores Pharm.D Pharmacy Resident at the Miami VA Healthcare System Review the epidemiology, pathophysiology

More information

Il loop recorder esterno. Roberto Maggi

Il loop recorder esterno. Roberto Maggi Il loop recorder esterno Roberto Maggi ECG monitoring and syncope In-hospital monitoring Holter Monitoring Event recorder External loop recorder Remote (at home) telemetry Implantable loop recorder External

More information

Frederik Meijer Heart & Vascular Institute

Frederik Meijer Heart & Vascular Institute Frederik Meijer Heart & Vascular Institute Evaluation of Atrial Fibrillation in the Outpatient Setting Musa I Dahu, MD, FHRS Electrophysiology Frederik Meijer Heart & Vascular Institute Clinical Assistant

More information

ANTICOAGULATION IN ATRIAL FIBRILLATION. Heather Kertland St Michael s Hospital University of Toronto

ANTICOAGULATION IN ATRIAL FIBRILLATION. Heather Kertland St Michael s Hospital University of Toronto ANTICOAGULATION IN ATRIAL FIBRILLATION Heather Kertland St Michael s Hospital University of Toronto Susan A 73 year old female admitted to the general medicine ward with pneumonia. She had been feeling

More information

PRACTICAL APPROACH TO SVT. Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia

PRACTICAL APPROACH TO SVT. Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia PRACTICAL APPROACH TO SVT Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia CONDUCTION SYSTEM OF THE HEART SA node His bundle Left bundle AV node Right

More information

New Anticoagulants and GI bleeding

New Anticoagulants and GI bleeding New Anticoagulants and GI bleeding DR DANNY MYERS MD FRCP(C) CLINICAL ASSISTANT PROFESSOR OF MEDICINE, UBC Conflicts of Interest None I am unbiased in the use of NOAC s vs Warfarin based on risk benefit

More information

Anticoagulants in Atrial Fibrillation

Anticoagulants in Atrial Fibrillation Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives

More information

Atrial Fibrillation (AF) Explained

Atrial Fibrillation (AF) Explained James Paget University Hospitals NHS Foundation Trust Atrial Fibrillation (AF) Explained Patient Information Contents What are the symptoms of atrial fibrillation (AF)? 3 Normal heartbeat 4 How common

More information

Diagnostic Electrophysiology & Ablation

Diagnostic Electrophysiology & Ablation Limited Ablation for Persistent Atrial Fibrillation Using Preprocedure Reverse Remodelling David Slotwiner 1 and Jonathan Steinberg 2 1. Assistant Professor of Cardiology, Hofstra North Shore-LIJ School

More information

Advances in the Treatment of Atrial Fibrillation At VCU Medical Center

Advances in the Treatment of Atrial Fibrillation At VCU Medical Center Contact Us For additional information or to schedule an appointment with one of our specialists, please call: Ken Ellenbogen, M.D. Cardiology/Electrophysiology 804-828-7565 or 804-628-0147 You can also

More information

1. Introduction. Correspondence should be addressed to Firat Duru; firat.duru@usz.ch

1. Introduction. Correspondence should be addressed to Firat Duru; firat.duru@usz.ch Cardiology Research and Practice, Article ID 179632, 8 pages http://dx.doi.org/1.1155/214/179632 Clinical Study Characterization of Pulmonary Vein Dimensions Using High-Definition 64-Slice Computed Tomography

More information

5 MILLION AMERICANS 1. Atrial Fibrillation (AFib) AFib affects an estimated

5 MILLION AMERICANS 1. Atrial Fibrillation (AFib) AFib affects an estimated A Patient s Guide To with Atrial Fibrillation (AFib) CAUSES RISK FACTORS SYMPTOMS DIAGNOSIS TREATMENTS INSIDE The Healthy Heart... 2 Your Heart In AFib... 4 How Do You Get It?... 6 How Do You Know If You

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

Health Policy Advisory Committee on Technology

Health Policy Advisory Committee on Technology Health Policy Advisory Committee on Technology Technology Brief Catheter ablation for atrial fibrillation July 2014 State of Queensland (Queensland Department of Health) 2014 This work is licensed under

More information

9/5/14. Objectives. Atrial Fibrillation (AF)

9/5/14. Objectives. Atrial Fibrillation (AF) Novel Anticoagulation for Prevention of Stroke in Patients with Atrial Fibrillation Objectives 1. Review current evidence on use of warfarin in individuals with atrial fibrillation 2. Compare the three

More information

What Should be the Primary Treatment in Atrial Fibrillation: Ventricular Rate Control or Sinus Rhythm Control with Long-term Anticoagulation?

What Should be the Primary Treatment in Atrial Fibrillation: Ventricular Rate Control or Sinus Rhythm Control with Long-term Anticoagulation? The Journal of International Medical Research 2009; 37: 464 471 What Should be the Primary Treatment in Atrial Fibrillation: Ventricular Rate Control or Sinus Rhythm Control with Long-term Anticoagulation?

More information

Protocol. Catheter Ablation as Treatment for Atrial Fibrillation

Protocol. Catheter Ablation as Treatment for Atrial Fibrillation Protocol Catheter Ablation as Treatment for Atrial Fibrillation (20219) (Formerly Catheter Ablation of the Pulmonary Veins as Treatment for Atrial Fibrillation) Medical Benefit Effective Date: 10/01/15

More information

UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD. Ex parte VINOD SHARMA and DANIEL C. SIGG

UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD. Ex parte VINOD SHARMA and DANIEL C. SIGG UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte VINOD SHARMA and DANIEL C. SIGG Appeal 2012-000284 Technology Center 1600 Before ERIC GRIMES, FRANCISCO C. PRATS,

More information

Atrial fibrillation. Quick reference guide. Issue date: June 2006. The management of atrial fibrillation

Atrial fibrillation. Quick reference guide. Issue date: June 2006. The management of atrial fibrillation Quick reference guide Issue date: June 2006 Atrial fibrillation The management of atrial fibrillation Developed by the National Collaborating Centre for Chronic Conditions Contents Contents Patient-centred

More information